Zinc and cadmium analysis in human prostate neoplasms

Biol Trace Elem Res. 1997 Winter;59(1-3):145-52. doi: 10.1007/BF02783239.


The objective of this study was to test the hypothesis that prostatic cancer is associated with the changes of zinc (Zn) and cadmium (Cd) concentration. Normal prostate, benign prostatic hyperplasia (BPH), and prostatic carcinoma (PCA) were analyzed for Zn and Cd by atomic absorption spectrometry. Cd level was measured using a graphite furnace and Zn level was measured by flame mode. Metal content was assessed in whole tissues and in nuclear, plasma membrane, and cytosolic fractions. An increase of Zn content in BPH, but a decrease in PCA as compared to normal tissue, was observed. Cd concentration appeared to be higher in BPH and PCA than in normal tissue. No correlation between Zn and Cd level was found in BPH specimens obtained from the same patients. Probability values of p < or = 0.05 were considered to indicate significant differences. Obtained results seem to support the hypothesis of Cd carcinogenicity and preventing function of Zn in prostatic cancer. Plasma membrane fraction corresponding to lysosomal, mitochondrial, and microsomal subcellular compartments are probably critical in Zn and Cd participation in human prostate neoplasms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cadmium / metabolism*
  • Humans
  • Male
  • Prostate / metabolism
  • Prostatic Hyperplasia / metabolism
  • Prostatic Neoplasms / metabolism*
  • Subcellular Fractions / metabolism
  • Zinc / metabolism*


  • Cadmium
  • Zinc